Hexagon Purus ASA: Results for the fourth quarter 2022 Read more about Hexagon Purus ASA: Results for the fourth quarter 2022
Hexagon Purus ASA: Results for the fourth quarter 2022 Read more about Hexagon Purus ASA: Results for the fourth quarter 2022
Ultimovacs provides updated guidance on timeline for readout of INITIUM Phase II clinical trial of UV1 in malignant melanoma Read more about Ultimovacs provides updated guidance on timeline for readout of INITIUM Phase II clinical trial of UV1 in malignant melanoma
NANOBIOTIX Provides Business Update and Reports Full Year 2022 Financial Results Read more about NANOBIOTIX Provides Business Update and Reports Full Year 2022 Financial Results
CORRECTING and REPLACING: TME Pharma Publishes Audited Annual Report 2022 Read more about CORRECTING and REPLACING: TME Pharma Publishes Audited Annual Report 2022
BAKKAFROST: Currency Rate for the upcoming Cash Dividend Read more about BAKKAFROST: Currency Rate for the upcoming Cash Dividend